Product Information
DILTIAZEM 24HR ER 120 MG CAP is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.2160 per EA under NDC 68682036790. Its NADAC has been published 565 times since Dec 10, 2014.
FDA first approved this application on Sep 11, 1995. Its Orange Book therapeutic-equivalence code is AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682036790
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020401FDA Approved
9/11/1995
TE Code
AB4
On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24HR ER 120 MG CAP has been published 565 times since Dec 10, 2014, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2160 per EA |
|---|---|
| All-time high | $0.5338 (Mar 11, 2015) |
| All-time low | $0.1688 (Nov 20, 2024) |
| Median price | $0.2866 |
| Average price | $0.3048 |
| Largest weekly change | +54.1% (May 22, 2019) |
| Weeks tracked | 565 |
| Tracking since | Dec 10, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+2.4%
5Y
-30.5%
All
-53.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 24HR ER 120 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24HR ER 120 MG CAP, manufactured by Oceanside Pharmaceuticals, is $0.2160 per EA (NDC 68682036790), effective Oct 1, 2025.
How has the price of DILTIAZEM 24HR ER 120 MG CAP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24HR ER 120 MG CAP has declined 53.6%. It has been tracked across 565 weekly CMS publications since Dec 10, 2014.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24HR ER 120 MG CAP?
Since Dec 10, 2014, the NADAC for DILTIAZEM 24HR ER 120 MG CAP has ranged from a low of $0.1688 (Nov 20, 2024) to a high of $0.5338 (Mar 11, 2015), with a median of $0.2866 per EA.
Are there cheaper alternatives to DILTIAZEM 24HR ER 120 MG CAP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIADYLT ER 120 MG CAPSULE, is $0.1054 per EA — about 51% below DILTIAZEM 24HR ER 120 MG CAP.
Who manufactures DILTIAZEM 24HR ER 120 MG CAP?
DILTIAZEM 24HR ER 120 MG CAP (NDC 68682036790) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.